calendar
20,413 catalysts · 4,728 grant · 3,706 8k filing · 2,859 device 510k · 2,736 approval · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
20,413 catalysts · 4,728 grant · 3,706 8k filing · 2,859 device 510k · 2,736 approval · 2,000 device pma · 2,000 device recall
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: To Be Discontinued. Reason: not specified. Form: Capsule
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Vanilla Bourbon Trail Mix
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 5.02, 9.01
Items: 1.02
Items: 8.01
Items: 8.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 5.02, 5.07, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S